SYGNOMICS aims to help clinicians improve patient outcomes at scale by accurately applying systems biology to cancer care.​

SYGNOMICS is developing an end-to-end solution that uses a unique and disruptive approach to enable personalized precision medicine for cancer patients. This solution will be powered by the Systems Genetics Network AnaLysis (SYGNAL) technology, which can accurately risk stratify a patient and personalize therapies (drugs and drug combinations) based on the unique characteristics of transcriptional “programs” underlying their disease.

Health Care

Health Data

Life Sciences

Therapeutics

Sygnomics

Sygnomics' headquarters in Seattle, United States

Description

People (4)

Ashutosh T.

Ashutosh Tiwary

Serdar Turkarslan

Thomas Brown

Jobs